콘텐츠로 건너뛰기
주식/증권 📈 긍정적

Here's Why You Should Retain DexCom Stock in Your Portfolio for Now

요약

DXCM's expanding CGM reach, G7 15 Day rollout and international momentum support growth, but can reimbursement and cost risks temper the outlook?